| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC | 4,780,188 | 200,242,000 | 65.32% | ||
| 2 | ImmuneDesign Corp. | 2,414,040 | 50,960,000 | 16.62% | ||
| 3 | AGILE THERAPEUTICS INC | 4,668,763 | 43,278,000 | 14.12% | ||
| 4 | ANTHERA PHARMACEUTICALS INC | 1,900,000 | 8,493,000 | 2.77% | ||
| 5 | Zosano Pharma Corp | 229,759 | 2,323,000 | 0.76% | ||
| 6 | MAST THERAPEUTICS INC | 2,551,851 | 1,238,000 | 0.40% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-020455, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
